AUG 18, 2026 · JOURNAL ARTICLE
Targeted therapy of colon cancer with aptamer-functionalized albumin nanoparticles loaded with disulfiram
Nanotechnology
Preclinical proof-of-concept in cell lines and xenograft models; no human trials, clinical efficacy data, or regulatory evidence reported.
Reported
Nanoparticle size96.4 ± 7.4 nm
Zeta potential−19.1 ± 2.2 mV